Journal article 958 views
Identification of small interfering RNA targeting signal transducer and activator of transcription-6: characterisation and selection of candidates for pre-clinical development
GD Healey,
S Zinnen,
J Lockridge,
I Richards,
N Evans,
W Walker,
William Walker 
J. RNAi Gene Silencing, Volume: 6, Pages: 401 - 10
Swansea University Author:
William Walker
Abstract
The interleukin (IL)-13 pathway and its associated transcription factor, signal transducer and activator of transcription 6 (STAT6), have been clearly implicated in the pathogenesis of bronchial asthma. We have developed a system to effectively screen the STAT6 gene for targeting with small interfer...
| Published in: | J. RNAi Gene Silencing |
|---|---|
| Published: |
J. RNAi Gene Silencing
2010
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa10001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract: |
The interleukin (IL)-13 pathway and its associated transcription factor, signal transducer and activator of transcription 6 (STAT6), have been clearly implicated in the pathogenesis of bronchial asthma. We have developed a system to effectively screen the STAT6 gene for targeting with small interfering (si) RNA molecules. By incorporating an in silico and in vitro screening system we were able to identify fourteen siRNA molecules suitable for pre-clinical drug development. Furthermore, we were able to demonstrate that modification of certain siRNAs, designed to improve in vivo longevity, was possible without significant loss of target knockdown efficacy and that the siRNA produced by our selection process did not induce demonstrable interferon responses. These data suggest that several STAT6-targeting siRNA suitable for pre-clinical development are available for potential use in the treatment of asthma. |
|---|---|
| College: |
Faculty of Medicine, Health and Life Sciences |
| Start Page: |
401 |
| End Page: |
10 |